Complete Filing Data
INTENSITY THERAPEUTICS, INC. reported Stockholders Equity of $11.88 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean INTENSITY THERAPEUTICS, INC. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Net Income Loss | -$11.6M | -$16.3M | -$10.5M | -$7.6M |
| Research And Development Expense | $6.8M | $10.5M | $4.8M | $5.1M |
| Operating Income Loss | -$12.0M | -$16.6M | -$8.3M | -$7.6M |
| Operating Expenses | $12.0M | $16.6M | $8.3M | $7.6M |
| General And Administrative Expense | $5.2M | $6.1M | $3.5M | $2.4M |
| Other Nonoperating Income | $3.0K | $24.0K | $48.0K | |
| Other Nonoperating Income Expense | $186.0K | $3.0K | ||
| Interest Expense | $305.0K | $82.0K | ||
| Net Income Loss From Continuing Operations Available To Common Shareholders Basic | -$16.3M | -$11.9M | -$7.6M | |
| Interest Expense Nonoperating | $0.00 | $305.0K | ||
| Net Income Loss Available To Common Stockholders Basic |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income Loss | -$2.7M | -$2.5M | -$3.3M | -$3.5M | -$5.0M | -$4.6M | -$2.3M | -$3.7M | -$1.3M | -$1.8M | -$1.9M |
| Research And Development Expense | $1.6M | $1.5M | $2.2M | $2.2M | $3.6M | $2.8M | $1.4M | $859.0K | $774.0K | $1.2M | $1.4M |
| Operating Income Loss | -$2.7M | -$2.7M | -$3.4M | -$3.6M | -$5.1M | -$4.7M | -$2.5M | -$1.2M | -$1.3M | -$1.8M | -$1.9M |
| Operating Expenses | $2.7M | $2.7M | $3.4M | $3.6M | $5.1M | $4.7M | $2.5M | $1.2M | $1.3M | $1.8M | $1.9M |
| General And Administrative Expense | $1.2M | $1.2M | $1.2M | $1.4M | $1.5M | $1.9M | $1.1M | $362.0K | $480.0K | $607.1K | $543.8K |
| Other Nonoperating Income | $0.00 | $0.00 | $13.2K | $4.0K | $1.0K | $7.1K | $16.9K | ||||
| Other Nonoperating Income Expense | $3.0K | $151.0K | $32.0K | $9.0K | $0.00 | $0.00 | $14.0K | ||||
| Interest Expense | $0.00 | $221.8K | $83.0K | $15.1K | $15.0K | ||||||
| Net Income Loss From Continuing Operations Available To Common Shareholders Basic | -$3.5M | -$5.0M | -$2.3M | -$5.0M | |||||||
| Interest Expense Nonoperating | $0.00 | $0.00 | $0.00 | $222.0K | |||||||
| Net Income Loss Available To Common Stockholders Basic | -$2.3M | -$1.8M |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Stockholders Equity | $11.9M | $2.9M | $13.2M | -$15.1M | -$8.7M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $11.9M | $2.6M | $8.6M | $1.3M | $4.5M |
| Cash And Cash Equivalents At Carrying Value | $11.9M | $2.6M | $8.6M | $1.3M | |
| Accrued Liabilities Current | $1.5M | $508.0K | $891.0K | $1.7M | |
| Temporary Equity Carrying Amount Attributable To Parent | $0.00 | $0.00 | $10.0M | $10.0M | |
| Retained Earnings Accumulated Deficit | -$78.4M | -$66.8M | -$50.5M | -$38.7M | |
| Other Assets Noncurrent | $1.3M | $1.3M | $1.7M | $167.0K | |
| Liabilities Current | $2.1M | $1.8M | $4.0M | $6.8M | |
| Liabilities And Stockholders Equity | $14.1M | $4.8M | $17.3M | $1.8M | |
| Liabilities | $2.2M | $1.9M | $4.1M | $6.9M | |
| Common Stock Value | $0.00 | $0.00 | $1.0K | $0.00 | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | $9.3M | -$6.0M | $7.2M | -$3.2M | |
| Assets Current | $12.7M | $3.4M | $15.5M | $1.5M | |
| Assets | $14.1M | $4.8M | $17.3M | $1.8M | |
| Accounts Payable Current | $583.0K | $1.2M | $3.0M | $603.0K | |
| Operating Lease Right Of Use Asset | $96.0K | $122.0K | $147.0K | $139.0K | |
| Operating Lease Liability Current | $31.0K | $28.0K | $20.0K | $143.0K | |
| Preferred Stock Value | $0.00 | $0.00 | $0.00 | $0.00 | |
| Operating Lease Right Of Use Asset Amortization Expense | $26.0K | $25.0K | $147.0K | $179.0K | |
| Operating Lease Liability Noncurrent | $79.0K | $110.0K | $138.0K | $0.00 | |
| Gains Losses On Extinguishment Of Debt | $0.00 | -$2.3M | $0.00 | ||
| Prepaid Expense And Other Assets Current | $788.0K | $773.0K | $688.0K | ||
| Amortization Of Debt Discount Premium | $0.00 | $159.0K | $0.00 | ||
| Preferred Stock Dividends Income Statement Impact | $0.00 | $1.3M | $0.00 | ||
| Other Liabilities Noncurrent | $0.00 | $36.0K | $36.0K | ||
| Debt Securities Available For Sale Excluding Accrued Interest Current | $0.00 | $6.2M | $0.00 | ||
| Warrants Issued Convertible Debt | $0.00 | $159.0K | $0.00 | ||
| Other Assets Current | $6.0K | $76.0K | |||
| Dividends Payable Current And Noncurrent | $0.00 | $1.3M | $0.00 | ||
| Right Of Use Asset Obtained In Exchange For Operating Lease Liability | $0.00 | $155.0K | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $7.2M | $2.2M | $334.0K | $2.8M | $5.3M | $9.7M | $15.9M | $15.1M | -$16.0M | -$14.2M | -$12.5M | -$10.8M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $7.1M | $2.2M | $929.0K | $2.8M | $3.2M | $7.5M | $6.7M | $136.0K | $616.0K | $696.6K | $1.7M | |
| Cash And Cash Equivalents At Carrying Value | $7.1M | $2.2M | $929.0K | $2.8M | $3.2M | $7.5M | $6.7M | $135.8K | $8.6M | |||
| Accrued Liabilities Current | $561.0K | $941.0K | $1.0M | $1.7M | $1.3M | $1.3M | $355.0K | $1.5M | $891.0K | |||
| Temporary Equity Carrying Amount Attributable To Parent | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $10.0M | ||||||
| Retained Earnings Accumulated Deficit | -$75.3M | -$72.7M | -$70.1M | -$63.6M | -$60.1M | -$55.1M | -$47.3M | -$43.7M | ||||
| Other Assets Noncurrent | $1.3M | $1.3M | $1.3M | $1.3M | $1.1M | $1.1M | $28.4K | $167.7K | ||||
| Liabilities Current | $2.3M | $2.2M | $2.6M | $2.3M | $3.2M | $2.5M | $724.0K | $3.1M | ||||
| Liabilities And Stockholders Equity | $9.6M | $4.4M | $3.1M | $5.2M | $8.7M | $12.4M | $16.8M | $18.2M | ||||
| Liabilities | $2.4M | $2.3M | $2.7M | $2.4M | $3.3M | $2.7M | $904.9K | $3.1M | ||||
| Common Stock Value | $5.0K | $3.0K | $2.0K | $1.0K | $1.0K | $1.0K | $1.4K | $1.3K | ||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$1.7M | -$1.1M | -$696.0K | |||||||||
| Assets Current | $8.2M | $3.0M | $1.7M | $3.8M | $7.4M | $11.2M | $16.6M | $18.1M | ||||
| Assets | $9.6M | $4.4M | $3.1M | $5.2M | $8.7M | $12.4M | $16.8M | $18.2M | ||||
| Accounts Payable Current | $1.7M | $1.2M | $1.6M | $540.0K | $1.9M | $1.2M | $358.4K | $1.6M | ||||
| Operating Lease Right Of Use Asset | $103.0K | $109.0K | $116.0K | $128.0K | $135.0K | $141.0K | $152.6K | |||||
| Operating Lease Liability Current | $31.0K | $30.0K | $29.0K | $28.0K | $27.0K | $26.0K | $10.6K | |||||
| Preferred Stock Value | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||||
| Operating Lease Right Of Use Asset Amortization Expense | $6.0K | $6.0K | $100.0K | |||||||||
| Operating Lease Liability Noncurrent | $87.0K | $95.0K | $102.0K | $117.0K | $124.0K | $131.0K | ||||||
| Gains Losses On Extinguishment Of Debt | $0.00 | $0.00 | $0.00 | -$2.3M | ||||||||
| Prepaid Expense And Other Assets Current | $1.1M | $822.0K | $722.0K | $1.0M | $1.1M | $672.0K | ||||||
| Amortization Of Debt Discount Premium | $0.00 | $13.0K | ||||||||||
| Preferred Stock Dividends Income Statement Impact | $0.00 | $0.00 | $0.00 | $1.3M | ||||||||
| Other Liabilities Noncurrent | $0.00 | $0.00 | $36.0K | |||||||||
| Debt Securities Available For Sale Excluding Accrued Interest Current | $0.00 | $3.1M | $3.0M | |||||||||
| Warrants Issued Convertible Debt | ||||||||||||
| Other Assets Current | $14.4K | $159.5K | ||||||||||
| Dividends Payable Current And Noncurrent | $0.00 | $0.00 | $1.3M | $1.3M | ||||||||
| Right Of Use Asset Obtained In Exchange For Operating Lease Liability |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Stock Issued During Period Value Share Based Compensation | $266.0K | $50.0K | ||
| Share Based Compensation | $2.0M | $3.1M | $1.4M | $1.2M |
| Net Cash Provided By Used In Operating Activities | -$9.2M | -$15.2M | -$7.2M | -$5.5M |
| Net Cash Provided By Used In Financing Activities | $18.6M | $2.9M | $20.5M | $2.3M |
| Net Cash Provided By Used In Investing Activities | $0.00 | $6.4M | -$6.0M | $0.00 |
| Increase Decrease In Accrued Interest Receivable Net | $0.00 | $134.0K | $197.0K | $0.00 |
| Proceeds From Sale And Maturity Of Available For Sale Securities | $0.00 | $9.4M | $9.0M | $0.00 |
| Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options | 56.0K | 321.0K | 50.0K | 0.00 |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | $13.0K | -$301.0K | $2.1M | -$53.0K |
| Increase Decrease In Accounts Payable And Accrued Liabilities | $360.0K | -$2.3M | $1.6M | $704.0K |
| Proceeds From Issuance Initial Public Offering | $4.7M | $0.00 | $22.4M | $0.00 |
| Payments To Acquire Available For Sale Securities Debt | $0.00 | $3.1M | $15.1M | $0.00 |
| Payments Of Stock Issuance Costs | $2.2M | $0.00 | ||
| Proceeds From Issuance Of Long Term Debt | $0.00 | $230.0K | $2.3M | |
| Payments For Repurchase Of Initial Public Offering | $0.00 | $2.2M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|
| Stock Issued During Period Value Share Based Compensation | $263.0K | $3.0K | $8.0K | $25.0K | $312.1K | $40.7K | $223.5K | ||
| Share Based Compensation | $435.0K | $1.2M | $312.0K | ||||||
| Net Cash Provided By Used In Operating Activities | -$2.0M | -$4.4M | -$901.0K | ||||||
| Net Cash Provided By Used In Financing Activities | $328.0K | $8.0K | $205.0K | ||||||
| Net Cash Provided By Used In Investing Activities | $0.00 | $3.3M | $0.00 | ||||||
| Increase Decrease In Accrued Interest Receivable Net | $0.00 | $79.0K | $0.00 | ||||||
| Proceeds From Sale And Maturity Of Available For Sale Securities | $0.00 | $3.3M | $0.00 | ||||||
| Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options | 0.00 | 8.0K | 0.00 | ||||||
| Increase Decrease In Prepaid Deferred Expense And Other Assets | -$51.0K | -$602.0K | -$10.0K | ||||||
| Increase Decrease In Accounts Payable And Accrued Liabilities | $866.0K | -$1.4M | $0.00 | ||||||
| Proceeds From Issuance Initial Public Offering | $19.5M | ||||||||
| Payments To Acquire Available For Sale Securities Debt | |||||||||
| Payments Of Stock Issuance Costs | $17.0K | $0.00 | $3.0M | ||||||
| Proceeds From Issuance Of Long Term Debt | $0.00 | $205.0K | |||||||
| Payments For Repurchase Of Initial Public Offering |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Weighted Average Number Of Shares Outstanding Basic | 1.4M | 556.3K | 8.6M | 3.4M | |
| Weighted Average Number Of Diluted Shares Outstanding | 1.4M | 556.3K | 8.6M | 3.4M | |
| Earnings Per Share Diluted | $-8.56 | $-29.24 | $-1.38 | $-2.22 | |
| Earnings Per Share Basic | $-8.56 | $-29.24 | $-1.38 | $-2.22 | |
| Temporary Equity Shares Outstanding | 0.00 | 0.00 | 5.0M | 5.0M | |
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | |
| Common Stock Shares Outstanding | 2.5M | 604.9K | 13.7M | 3.4M | |
| Common Stock Shares Issued | 2.5M | 604.9K | 13.7M | 3.4M | |
| Common Stock Shares Authorized | 135.0M | 135.0M | 135.0M | 50.0M | |
| Preferred Stock Shares Authorized | 15.0M | 15.0M | 15.0M | 20.0M | |
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | |
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | ||
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Weighted Average Number Of Shares Outstanding Basic | 43.0M | 18.9M | 15.2M | 13.8M | 13.7M | 13.7M | 13.7M | 3.5M | 3.4M | 3.4M | 3.4M | |
| Weighted Average Number Of Diluted Shares Outstanding | 43.0M | 18.9M | 15.2M | 13.8M | 13.7M | 13.7M | 13.7M | 3.5M | 3.4M | 3.4M | 3.4M | |
| Earnings Per Share Diluted | $-0.06 | $-0.13 | $-0.22 | $-0.25 | $-0.36 | $-0.34 | $-0.17 | $-1.43 | $-0.39 | $-0.52 | $-0.57 | |
| Earnings Per Share Basic | $-0.06 | $-0.13 | $-0.22 | $-0.25 | $-0.36 | $-0.34 | $-0.17 | $-1.43 | $-0.39 | $-0.52 | $-0.57 | |
| Temporary Equity Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 5.0M | ||||||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||||
| Common Stock Shares Outstanding | 49.1M | 26.2M | 15.3M | 13.9M | 13.7M | 13.7M | 13.7M | |||||
| Common Stock Shares Issued | 49.1M | 26.2M | 15.3M | 13.9M | 13.7M | 13.7M | 13.7M | |||||
| Common Stock Shares Authorized | 135.0M | 135.0M | 135.0M | 135.0M | 135.0M | 135.0M | 135.0M | |||||
| Preferred Stock Shares Authorized | 15.0M | 15.0M | 15.0M | 15.0M | 15.0M | 15.0M | 15.0M | |||||
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||||
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 15.0M | |||||
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 15.0M |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Investment Income Interest | $180.0K | $314.0K | $324.0K | $2.0K |
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $2.0M | $3.1M | $1.4M | $1.2M |
| Additional Paid In Capital | $90.3M | $69.7M | $63.7M | $23.6M |
| Stock Issued During Period Value New Issues | $3.6M | $1.4M | $19.0M | |
| Stock Issued1 | $0.00 | $51.0K | $4.7M | $0.00 |
| Adjustments To Additional Paid In Capital Stock Issued Issuance Costs | $412.0K | $321.0K | $3.4M | |
| Stock Issued During Period Value Conversion Of Convertible Securities | $56.0K | $55.0K | ||
| Warrants Issued Stock Issuance | $1.0M | $1.1M | $1.2M | $0.00 |
| Stock Issued In Exchange For Services | $0.00 | $51.0K | $0.00 | |
| Adjustments To Additional Paid In Capital Warrant Issued | $159.0K | |||
| Warrants Issued To Underwriters In Connection With Public Offering |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Investment Income Interest | $59.0K | $17.0K | $15.0K | $48.0K | $98.0K | $140.0K | $148.0K | $0.00 | $0.00 | $988.00 | $213.00 |
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $471.0K | $644.0K | $435.0K | $483.0K | $591.0K | $1.2M | $351.0K | $312.0K | $312.0K | ||
| Additional Paid In Capital | $82.6M | $74.8M | $70.5M | $66.4M | $65.4M | $64.8M | $63.3M | $58.8M | |||
| Stock Issued During Period Value New Issues | $2.7M | $328.0K | $150.0K | $2.6M | $16.5M | ||||||
| Stock Issued1 | |||||||||||
| Adjustments To Additional Paid In Capital Stock Issued Issuance Costs | $301.0K | $698.0K | $17.0K | $82.0K | |||||||
| Stock Issued During Period Value Conversion Of Convertible Securities | $8.0K | $7.0M | |||||||||
| Warrants Issued Stock Issuance | |||||||||||
| Stock Issued In Exchange For Services | |||||||||||
| Adjustments To Additional Paid In Capital Warrant Issued | $159.0K | ||||||||||
| Warrants Issued To Underwriters In Connection With Public Offering | $152.6K | $1.0M |
Most recent annual filing with the SEC: March 27, 2026
Data sourced from SEC EDGAR public filings as of August 5, 2026.